Tata laksana Infeksi Sitomegalovirus pada Pasien Transplantasi Organ Padat
Sari
Pasien kandidat transplan organ padat merupakan populasi yang berisiko tinggi mengalami infeksi, terutama setelah transplantasi, karena pasien akan menerima terapi imunosupresan sehingga infeksi maupun reaktivasi patogen lebih mudah terjadi. Patogen penyebab morbiditas tersering adalah sitomegalovirus (CMV). Infeksi sitomegalovirus dapat bersifat simtomatik maupun asimtomatik. Penyakit CMV timbul apabila infeksi bersifat simtomatik dan dapat terjadi baik oleh infeksi primer, reaktivasi, maupun superinfeksi virus. Gejala penyakit CMV pada pasien imunokompromais dapat menjadi diseminata. Baku emas untuk mendiagnosis CMV adalah dengan polymerase chain reaction (PCR) CMV. Namun demikian, belum ada panduan tatalaksana profilaksis maupun batasan titer CMV yang memerlukan terapi. Makalah ini bertujuan untuk menelaah literatur sehingga dapat menghasilkan panduan profilaksis dan terapi penyakit CMV pada pasien transplantasi organ padat di Indonesia.
Kata Kunci
Teks Lengkap:
PDFReferensi
Green M, Michaels MG. Infections in pediatric solid organ transplant recipients. J Pediatr Infect Dis Soc 2012;1:144–51.
Halasa N, Green M. Immunizations and infectious diseases in pediatric liver transplantation. Liver Transpl 2008;14:1389–99.
Fagiuoli S, Colli A, Bruno R, dkk. Management of infections pre- and post-liver transplantation: Report of an AISF consensus conference. J Hepatol 2014;60:1075–89.
Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: A review. Infect Chemother 2013;45:260–71.
Breinig MK, Zitelli B, Starzl TE, Ho M. Epstein-Barr virus,cytomegalovirus, and other viral infections in children after liver transplantation. J Infect Dis 1987;156:273–9.
Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007;357:2601–14.
Roman A, Manito N, Campistol JM, dkk. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients. Transplant Rev Orlando Fla 2014;28:84–91.
Emery VC, Cope AV, Bowen EF, Gor D, Griffiths PD. The dynamics of human cytomegalovirus replication in vivo. J Exp Med 1999;190:177–82.
Eid AJ, Brown RA, Arthurs SK, Lahr BD, Eckel-Passow JE, Larson TS, Razonable RR. A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection. Transpl Int 2010;23:506–13.
Paya C, Humar A, Dominguez E, dkk. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004;4:611–20.
Stowell JD, Forlin-Passoni D, Din E, dkk. Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission. J Infect Dis 2012;205:211–4.
Watkins RR, Lemonovich TL, Razonable RR. Immune response to CMV in solid organ transplant recipients: current concepts and future directions. Expert Rev Clin Immunol 2012;8:383–93.
Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev 2013;26:703–27.
Grefte A, van der Giessen M, van Son W, The TH. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis 1993;167:270–7.
Dunn HS, Haney DJ, Ghanekar SA, Stepick-Biek P, Lewis DB, Maecker HT. Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J Infect Dis 2002;186:15–22.
Humar A, Snydman D, AST Infectious diseases community of practice. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009;9 Suppl 4:S78–86.
Larsson S, Söderberg-Nauclér C, Wang FZ, Möller E. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 1998;38:271–8.
Gozlan J, Salord JM, Chouaïd C, Duvivier C, Picard O, Meyohas MC, Petit JC. Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection. J Clin Microbiol 1993;31:1943–5.
Randhawa PS, Manez R, Frye B, Ehrlich GD. Circulating immediate-early mRNA in patients with cytomegalovirus infections after solid organ transplantation. J Infect Dis 1994;170:1264–7.
Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG, Corey L. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol 2004;42:1142–8.
Eckart P, Brouard J, Vabret A, Freymuth F, Guillot M, Ryckelynck JP, Hurault de Ligny. Detection of human cytomegalovirus in renal transplantation: comparison of four diagnostic methods: DNA in sera by polymerase chain reaction (PCR), DNA in leukocyte by PCR, pp65 leukocytic antigenemia, and viremia. Transplant Proc 1997;29:2387–9.
Cunningham R, Harris A, Frankton A, Irving W. Detection of cytomegalovirus using PCR in serum from renal transplant recipients. J Clin Pathol 1995;48:575–7.
Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J Infect Dis 1995;172:527–31.
Revello MG, Percivalle E, Sarasini A, Baldanti F, Furione M, Gerna G. Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J Infect Dis 1994;170:1275–9.
Harper TW, Miller D, Schiffman JC, Davis JL. Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol 2009;147:140–7.e2.
Chemaly RF, Yen-Lieberman B, Chapman J, dkk. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant 2005;5:544–8.
Stéphan F, Fajac A, Grenet D, dkk. Predictive value of cytomegalovirus DNA detection by polymerase chain reaction in blood and bronchoalveolar lavage in lung transplant patients. Transplantation 1997;63:1430–5.
Chemaly RF, Yen-Lieberman B, Castilla EA, dkk. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and
immunohistochemistry. J Clin Microbiol 2004;42:2168–72.
Kerschner H, Jaksch P, Zweytick B, Puchhammer-Stöckl E. Detection of human cytomegalovirus in bronchoalveolar lavage fluid of lung transplant recipients reflects local virus replication and not contamination from the throat. J Clin Microbiol 2010;48:4273–4.
Razonable RR, Humar A, AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ
transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg 2013;13 Suppl 4:93–106.
Sia IG, Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 2000;13:83–121.
Piiparinen H, Höckerstedt K, Grönhagen-Riska C, Lautenschlager I. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J Clin Virol 2004;30:258–66.
Razonable RR, Ã…sberg A, Rollag H, Duncan J, Boisvert D, Yao JD, dkk. Virologic suppression measured by a cytomegalovirus (CMV) DNA test calibrated to the World Health Organization international standard is predictive of CMV disease resolution in transplant recipients. Clin Infect
Dis 2013;56:1546–53.
Green M, Marian M. Preemptive therapy of cytomegalovirus disease in pediatric transplant recipients. Pediatr Infect Dis J 2000;19:875-7.
Kim JM, Kwon CHD, Joh J-W, dkk. Oral valganciclovir as a preemptive treatment for cytomegalovirus (CMV) Infection in CMV-seropositive liver transplant recipients. PLOS ONE 2015;10:e0123554.
Bodro M, Sabé N, Lladó L, dkk. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients. Liver Transpl 2012;18:1093–9.
Danziger-Isakov LA, Worley S, Michaels MG, dkk. The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation. Transplantation 2009;87:1541–8.
MartÃn-Gandul C, Pérez-Romero P, González-Roncero FM, dkk. Clinical impact of neutropenia related with the preemptive therapy of CMV infection in solid organ transplant recipients. J Infect 2014;69:500–6.
Allen U, Hebert D, Petric M, dkk. Utility of semiquantitative polymerase chain reaction for Epstein-Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease. Clin Infect Dis 2001;33:145–50.
DOI: http://dx.doi.org/10.14238/sp19.3.2017.172-82
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc-sa4.footer##
Email: editorial [at] saripediatri.org
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.